The results showed that miR-485-3p was significantly up-regulated in serum of PD patients compared with that in both Alzheimer's disease (AD) and healthy cases, and had diagnostic accuracy for PD screening. The activated microglia BV2 cells induced by LPS also had elevated miR-485-3p, and...
The retraction has been agreed because the authors have been unable to reproduce the differences in serum miR-485-3p expression in patients with Alzheimer’s disease. Thus, the conclusion that serum miR-485-3p is a diagnostic biomarker of Alzheimer’s disease may not be reliable." Reply permali...
The present invention relates to a method for providing information for the diagnosis of Alzheimer′s disease or a brain disease using miR-485-3p and to a composition and a kit for the diagnosis of Alzheimer′s disease or a brain disease. The present invention enables an objective data analysi...
Furthermore, BMD-001 can be a promising candidate for treatment of AD pathology and cognitive decline, establishing a new paradigm in the AD field.doi:10.1002/alz.064410HanSeok KohHyun Su MinYu Na LimHannah JangJinhee YangDaehoon KimHyunJeong ChoJinHyeob RyuAlzheimer's & Dementia...
The present invention relates to an information providing method for diagnosing Alzheimer′s disease or brain diseases by using miR-485-3p, a composition for diagnosing Alzheimer′s disease or brain diseases, and a diagnostic kit. According to the present invention, objective data analysis for the ...
The present invention relates to a method for providing information for the diagnosis of Alzheimer′s disease or a brain disease using miR-485-3p and to a composition and a kit for the diagnosis of Alzheimer′s disease or a brain disease. The present invention enables an objective data ...
According to the present invention, objective data analysis for diagnosis of Alzheimer′s disease or brain disease is possible by measuring an expression level of miR-485-3p in the blood, and the risk in patients is minimized by measuring the concentration of amyloid beta 42 in saliva while ...